Standard Tigecycline Administration
Tigecycline, a glycylcycline antibiotic, is given intravenously as a 100 mg loading dose over 30-60 minutes, followed by 50 mg every 12 hours. Infuse through a dedicated line or Y-site compatible with 0.9% sodium chloride or dextrose 5% in water. Avoid rapid infusion to prevent nausea or phlebotoxicity.[1]
Adjustments for Allergic Patients
No specific administration changes exist for tigecycline in patients with allergies to unrelated drugs. Tigecycline allergies are rare (anaphylaxis reported in <0.1% of cases). Screen for tetracycline-class hypersensitivity first, as cross-reactivity is possible but uncommon (tigecycline modifies tetracycline structure to reduce resistance).[2][3]
Premedicate with antihistamines (e.g., diphenhydramine 25-50 mg IV) or corticosteroids (e.g., methylprednisolone 40-125 mg IV) if prior reactions suggest risk. Monitor closely during first dose for rash, hypotension, or bronchospasm. Have epinephrine 1:1000 ready. Switch to non-IV alternatives if severe allergy confirmed.[1][4]
What If Allergic to Tetracyclines?
Contraindicated in known tetracycline hypersensitivity due to potential cross-reactivity (e.g., hives, anaphylaxis). Use alternatives like vancomycin, linezolid, or daptomycin for resistant infections (e.g., MRSA, VRE). Desensitization protocols exist for tetracyclines but lack tigecycline-specific data—consult allergist.[2][5]
Common Side Effects vs. Allergic Reactions
Nausea (26%), vomiting (18%), diarrhea (13%) are frequent but not allergic. True allergies mimic beta-lactam reactions: urticaria, angioedema, or shock. Report suspected anaphylaxis to FDA MedWatch.[1][3]
Hospital Protocols and Monitoring
Administer in setting with resuscitation equipment. Baseline vital signs, then continuous monitoring for 30-60 minutes post-infusion. For outpatient or transition care, ensure allergy documentation in records.[4]
Sources
[1]: Tygacil (tigecycline) Prescribing Information - Pfizer
[2]: UpToDate: Tigecycline Drug Information
[3]: FDA Adverse Event Reporting System (FAERS) Summary
[4]: ASHP Guidelines on Antimicrobial Prophylaxis
[5]: Journal of Allergy and Clinical Immunology: Antibiotic Desensitization